Skip to content
OpenCapital
Get started

Avanos Medical AVNS Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate

Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
3%+2.9pp

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate.

The official record: Avanos Medical’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's effective income tax rate reconciliation change in enacted tax rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's effective income tax rate reconciliation change in enacted tax rate?
Avanos Medical (AVNS) reported effective income tax rate reconciliation change in enacted tax rate of 0% in Q4 2025.
What does effective income tax rate reconciliation change in enacted tax rate mean?
Represents the percentage impact on the effective tax rate due to changes in enacted tax rates. This metric is used to evaluate the sensitivity of the company's tax profile to shifts in government fiscal policy.